CLINICAL_TRIALS
trial_result
· 2023-05-11
Clinical Trial Update: Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand [Phase 2]
Summary
Phase 2 trial evaluating incobotulinum toxin A (Xeomin) for focal task-specific dystonia of the musician's hand has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Dystonia | Phase 2 | Status: COMPLETED | Results posted: 2023-05-11